Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

VIR BIOTECHNOLOGY, INC. (VIR)

  • Business News
  • Aug. 05, 2026, 20:05 UTC
  • 1
  • 1 comments

Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Market reaction Comment Full text

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

  • Business News
  • Aug. 05, 2026, 20:05 UTC
  • 0
  • 1 comments

PacBio Announces Second Quarter 2026 Financial Results

Market reaction Comment Full text

ENVISTA HOLDINGS CORP (NVST)

  • Business News
  • Aug. 05, 2026, 20:05 UTC
  • 0
  • 1 comments

Envista Reports Second Quarter 2026 Results

Market reaction Comment Full text

CHIRON REAL ESTATE INC. (XRN)

  • Business News
  • Aug. 05, 2026, 20:05 UTC
  • 0
  • 1 comments

Chiron Real Estate Inc. Announces Second Quarter 2026 Financial Results

Market reaction Comment Full text

DATADOG, INC. (DDOG)

  • Business News
  • Aug. 05, 2026, 20:05 UTC
  • 0
  • 1 comments

Datadog to Present at Upcoming Investor Conferences

Market reaction Comment Full text

RUNWAY GROWTH FINANCE CORP. (RWAY)

  • Business News
  • Aug. 05, 2026, 20:05 UTC
  • 0
  • 1 comments

Runway Growth Finance Corp. Announces Third Quarter 2026 Dividend of $0.33 per Share

Market reaction Comment Full text

TRUPANION, INC. (TRUP)

  • Business News
  • Aug. 05, 2026, 20:05 UTC
  • 0
  • 1 comments

Trupanion Reports Second Quarter 2026 Results

Market reaction Comment Full text

TASKUS, INC. (TASK)

  • Business News
  • Aug. 05, 2026, 20:05 UTC
  • 0
  • 1 comments

TaskUs Announces Fiscal Second Quarter 2026 Results

Market reaction Comment Full text

REMITLY GLOBAL, INC. (RELY)

  • Business News
  • Aug. 05, 2026, 20:05 UTC
  • 0
  • 1 comments

Remitly Reports Record Second Quarter Results and Raises Full Year 2026 Outlook

Market reaction Comment Full text

EVOLUS, INC. (EOLS)

  • Business News
  • Aug. 05, 2026, 20:05 UTC
  • 0
  • 1 comments

Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook

Market reaction Comment Full text
  • Previous
  • 254
  • 255
  • 256
  • 257
  • 258
  • Next

Search

News categories

  • Technical Exchange News(14168)
  • Event(6229)
  • SEC News(361397)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(222269)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin